Latest News and Press Releases
Want to stay updated on the latest news?
-
–Excluding European ORLADEYO revenue for the full year 2025, preliminary 2025 ORLADEYO net revenue was $563 million (+43 percent y-o-y on a comparable basis)– –ORLADEYO net revenue expected to be...
-
MediWound Provides Corporate Update and Financial Outlook Ahead of the J.P. Morgan Healthcare Conference Interim assessment and enrollment completion for the EscharEx® VALUE Phase III trial in...
-
_____________________________________ Acquires Bloc83 in CBD Raleigh in Joint Venture with the North Carolina Investment Authority$21.0M Total Investment (at HIW 10% Share)492,000 Square Feet, 97%...
-
BOCA RATON, Fla., Jan. 12, 2026 (GLOBE NEWSWIRE) -- NewtekOne, Inc. (“NewtekOne”) today announced that the expiration date with respect to its previously announced offer to exchange (the “Exchange...
-
KEY Investment Partners has purchased BellRock Brands out of receivership; industry leader Joe Bayern to lead new company, MM Brands.
-
ALACHUA, Fla. and TAMPA, Fla., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of...
-
Full-year 2025 preliminary1 U.S. net product revenues of $689 millionSYFOVRE® (pegcetacoplan injection) total injection demand grew 17% year-over-year; regulatory submission for prefilled syringe...
-
Net Sales Increase of 23.2% to $1.5 Billion; Comparable Sales Increase of 14.5% Increases Fourth Quarter and Full Year Fiscal 2025 Outlook PHILADELPHIA, PA, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Five...
-
WYOMISSING, Pa., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Gaming and Leisure Properties, Inc. (NASDAQ: GLPI) announced today that the Company will release its 2025 fourth quarter financial results after...
-
Lexeo Therapeutics Announces Positive Interim Phase I/II Data for LX2020 for the Treatment of PKP2-Associated Arrhythmogenic Cardiomyopathy